Has Kristen Pitts, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,477 in general payments to Kristen Pitts, MD across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kristen Pitts, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kristen Pitts, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kristen Pitts, MD

Otolaryngology · Spartanburg, SCNPI 1891107702

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.8% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $922, 2.0 times the $457 reported in 2019.

$2,477in general payments, 2019–2025

Across 93 payments — averaging $26.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$476
Integra Lifesciences Corporation$475
Aerin Medical Inc.$210
Intersect ENT, Inc.$155
Smith+Nephew$141
Stryker$94
plus $925 from 22 others

What the payments were for

Food & beverage$2,34895%
Education$1285%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	31	$476
Integra Lifesciences Corporation	4	$475
Aerin Medical Inc.	6	$210
Intersect ENT, Inc.	2	$155
Smith+Nephew	3	$141
Stryker	4	$94
Acclarent, Inc	1	$92
Optinose US, Inc.	6	$90
Sanofi	4	$74
Phathom Pharmaceuticals, Inc.	4	$68
3nt Medical	1	$64
Merck	2	$58
Regeneron Healthcare Solutions, Inc.	2	$52
Alk-abello, Inc	3	$49
Resmed Corp	3	$43
Lilly USA, LLC	2	$40
Amgen	2	$37
Medtronic	2	$37
AstraZeneca	2	$34
Novartis	1	$33
Baxter Healthcare	1	$27
Genentech USA, Inc.	1	$27
Hikma Pharmaceuticals USA	1	$22
ARS Pharmaceuticals Operations, Inc.	1	$21
Acera Surgical, Inc.	1	$21
Inspire Medical Systems, Inc.	1	$16
Kaleo, Inc.	1	$15
Forte Bio-pharma LLC	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,477 in reported general payments places this provider in the 65th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$198,100

Medicare patients

579

Services billed

2,779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	94	$2,604
Mometasone Furoate	15	$1,793
Triamcinolone Acetonide	26	$1,323
Dexamethasone Sodium Phosphate	28	$1,174
Pantoprazole Sodium	72	$773
Fluocinolone Acetonide Oil	24	$691
Montelukast Sodium	50	$691
Mupirocin	51	$642
Fluticasone Propionate	55	$527
Azelastine Hcl	18	$518
Lidocaine Hcl ViscousLidocaine Hcl	17	$316
Doxycycline Hyclate	50	$289
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	33	$269
Ciprofloxacin Hcl	27	$257
Prednisone	71	$156

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Spartanburg

John FosterSpartanburg$4K
Mitchell WorleySpartanburg$4K
David WeirSpartanburg$3K
Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Zachary SolerCharleston$67K
Peter HorwichNorth Charleston$33K
Eugene BrownCharleston$28K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →